Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease
National Taiwan University Hospital · National Cheng Kung University Hospital · +15 more institutions
Indexed incrossrefpubmed
Abstract
Background
Coexistence of metabolic dysfunction-associated steatotic liver disease (MASLD) increases hepatocellular carcinoma (HCC) risk after HCV cure.
Objective
The specific impacts of steatosis grade and cardiometabolic burden on HCC risk among patients with MASLD remain unclear.
Citation impact
7
total citations
- FWCI
- 108.37
- Percentile
- 100%
- References
- 62
Too recent for citation history.
Authors
21Topics & keywords
Topics
Keywords
- Steatosis
- Hepatocellular carcinoma
- Liver steatosis
- Hepatitis C
- Metabolic syndrome
- Hepatitis C virus
- Fatty liver
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.